These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. BMS-181885, a 5-HT1B/1D receptor ligand, in experimental models predictive of antimigraine activity and coronary side-effect potential. Saxena PR; De Vries P; Heiligers JP; Bax WA; Maassen VanDenBrink A; Yocca FD Eur J Pharmacol; 1998 Jun; 351(3):329-39. PubMed ID: 9721025 [TBL] [Abstract][Full Text] [Related]
3. Investigation of the role of 5-HT1B and 5-HT1D receptors in the sumatriptan-induced constriction of porcine carotid arteriovenous anastomoses. De Vries P; Willems EW; Heiligers JP; Villalón CM; Saxena PR Br J Pharmacol; 1999 May; 127(2):405-12. PubMed ID: 10385240 [TBL] [Abstract][Full Text] [Related]
4. Porcine carotid vascular effects of eletriptan (UK-116,044): a new 5-HT1B/1D receptor agonist with anti-migraine activity. Willems E; De Vries P; Heiligers JP; Saxena PR Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):212-9. PubMed ID: 9750007 [TBL] [Abstract][Full Text] [Related]
5. Characterization of 5-HT receptors mediating constriction of porcine carotid arteriovenous anastomoses; involvement of 5-HT1B/1D and novel receptors. De Vries P; Villalón CM; Heiligers JP; Saxena PR Br J Pharmacol; 1998 Apr; 123(8):1561-70. PubMed ID: 9605562 [TBL] [Abstract][Full Text] [Related]
6. Effects of avitriptan, a new 5-HT 1B/1D receptor agonist, in experimental models predictive of antimigraine activity and coronary side-effect potential. Saxena PR; De Vries P; Wang W; Heiligers JP; Maassen vandenBrink A; Bax WA; Yocca FD Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):295-302. PubMed ID: 9050026 [TBL] [Abstract][Full Text] [Related]
7. Effects of donitriptan on carotid haemodynamics and cardiac output distribution in anaesthetized pigs. Tom B; De Vries P; Heiligers JP; Willems EW; Kapoor K; John GW; Saxena PR Cephalalgia; 2002 Feb; 22(1):37-47. PubMed ID: 11993612 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological evidence that alpha1-and alpha2-adrenoceptors mediate vasoconstriction of carotid arteriovenous anastomoses in anaesthetized pigs. Willems EW; Trion M; De Vries P; Heiligers JP; Villalón CM; Saxena PR Br J Pharmacol; 1999 Jul; 127(5):1263-71. PubMed ID: 10455274 [TBL] [Abstract][Full Text] [Related]
9. Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors. Villalón CM; De Vries P; Rabelo G; Centurión D; Sánchez-López A; Saxena P Br J Pharmacol; 1999 Feb; 126(3):585-94. PubMed ID: 10188968 [TBL] [Abstract][Full Text] [Related]
10. Selective vasoconstriction by alniditan in the carotid vascular bed of anaesthetized dogs. Van de Water A; D'Aubioul J; Van Gerven W; Van Ammel K; De Clerck F Eur J Pharmacol; 1996 Mar; 299(1-3):127-37. PubMed ID: 8901015 [TBL] [Abstract][Full Text] [Related]
11. Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell lines. Lesage AS; Wouters R; Van Gompel P; Heylen L; Vanhoenacker P; Haegeman G; Luyten WH; Leysen JE Br J Pharmacol; 1998 Apr; 123(8):1655-65. PubMed ID: 9605573 [TBL] [Abstract][Full Text] [Related]
12. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan. Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979 [TBL] [Abstract][Full Text] [Related]
13. Unravelling the pharmacological profile of the canine external carotid vasodilator '5-HT1-like' receptors: coexistence of sympatho-inhibitory 5-HT1B and postjunctional 5-HT7 receptors. Villalón CM; Sánchez-López A; Centurión D; Saxena PR Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):73-80. PubMed ID: 11191839 [TBL] [Abstract][Full Text] [Related]
14. 5-HT(1A) and 5-HT(1B/1D) receptors are involved in the modulation of the trigeminovascular system of the cat: a microiontophoretic study. Boers PM; Donaldson C; Zagami AS; Lambert GA Neuropharmacology; 2000 Jul; 39(10):1833-47. PubMed ID: 10884564 [TBL] [Abstract][Full Text] [Related]
15. Blockade of porcine carotid vascular response to sumatriptan by GR 127935, a selective 5-HT1D receptor antagonist. De Vries P; Heiligers JP; Villalón CM; Saxena PR Br J Pharmacol; 1996 May; 118(1):85-92. PubMed ID: 8733580 [TBL] [Abstract][Full Text] [Related]
16. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy. Newman-Tancredi A; Conte C; Chaput C; Verrièle L; Audinot-Bouchez V; Lochon S; Lavielle G; Millan MJ Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):682-8. PubMed ID: 9205951 [TBL] [Abstract][Full Text] [Related]
17. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries. Ellwood AJ; Curtis MJ Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503 [TBL] [Abstract][Full Text] [Related]
18. Mediation of 5-HT-induced internal carotid vasodilatation in GR127935- and ritanserin-pretreated dogs by 5-HT7 receptors. Centurión D; Sánchez-López A; Ortiz MI; De Vries P; Saxena PR; Villalón CM Naunyn Schmiedebergs Arch Pharmacol; 2000 Aug; 362(2):169-76. PubMed ID: 10961380 [TBL] [Abstract][Full Text] [Related]
19. Effects of alniditan on neurogenic oedema in the rat dura mater and on contraction of rat basilar artery. Limmroth V; Bischoff A; Fetscher C; Wermelskirchen D; Diener H; Michel MC Eur J Pharmacol; 1999 Oct; 382(2):103-9. PubMed ID: 10528144 [TBL] [Abstract][Full Text] [Related]
20. Donitriptan, but not sumatriptan, inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors. Muñoz-Islas E; Gupta S; Jiménez-Mena LR; Lozano-Cuenca J; Sánchez-López A; Centurión D; Mehrotra S; MaassenVanDenBrink A; Villalón CM Br J Pharmacol; 2006 Sep; 149(1):82-91. PubMed ID: 16880765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]